000 01549 a2200433 4500
005 20250511195517.0
264 0 _c19910829
008 199108s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(91)90311-r
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSalaris, S C
245 0 0 _aMethylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury.
_h[electronic resource]
260 _bBiochemical pharmacology
_cJul 1991
300 _a499-506 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aHypoxanthine
650 0 4 _aHypoxanthines
_xmetabolism
650 0 4 _aIn Vitro Techniques
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLipid Peroxidation
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMethylene Blue
_xmetabolism
650 0 4 _aModels, Biological
650 0 4 _aOxidation-Reduction
650 0 4 _aRats
650 0 4 _aReperfusion Injury
_xprevention & control
650 0 4 _aSuccimer
650 0 4 _aSuperoxides
_xmetabolism
650 0 4 _aXanthine
650 0 4 _aXanthine Oxidase
_xantagonists & inhibitors
650 0 4 _aXanthines
_xmetabolism
700 1 _aBabbs, C F
700 1 _aVoorhees, W D
773 0 _tBiochemical pharmacology
_gvol. 42
_gno. 3
_gp. 499-506
856 4 0 _uhttps://doi.org/10.1016/0006-2952(91)90311-r
_zAvailable from publisher's website
999 _c1656692
_d1656692